Salesforce, Inc. (CRM) climbs 10% on earnings beat
Salesforce, Inc. (CRM) climbs after hours following fiscal Q2 2027 results, a raised full-year revenue outlook, and an expanded Anthropic partnership. Investors are reacting to a big adjusted EPS beat and growing AI and data recurring revenue, though part of the quarter was boosted by an investment gain.
Salesforce, Inc. (CRM) climbed 10.3% in extended-hours trading after reporting fiscal Q2 2027 results that beat expectations and lifting full-year revenue guidance. The move reflects stronger confidence in Salesforce’s AI and data growth, but investors should separate recurring operating momentum from the one-time investment gain that boosted earnings.
Salesforce, Inc. (CRM) climbs sharply in extended-hours trading, with its latest 8:30 a.m. ET print at $226.88, up 10.34% from the prior close of $205.62. The move follows fiscal Q2 2027 results, higher full-year guidance, and an expanded Anthropic partnership. Regular-session trading will confirm whether the gain holds.
Key Takeaways
CRM's latest extended-hours print gained 10.34%, moving from $205.62 to $226.88.
The clearest catalyst was Salesforce's Aug. 26 fiscal Q2 report and raised FY27 revenue guidance.
Adjusted EPS reached $5.90 versus a consensus estimate near $3.27, although a $2.6B Anthropic investment gain boosted results.
AI and data annual recurring revenue is approaching $4B, giving Agentforce a measurable commercial foundation.
Investors can treat the surge as a strong reset in sentiment, while separating durable operating growth from investment-related earnings.
What's Driving Salesforce (CRM) Higher After Hours
This is a company-specific earnings reaction, not a mystery move. Salesforce reported fiscal Q2 2027 results after the close on Aug. 26. Its described a record quarter and raised the company's annual revenue outlook.
The headline surprise came from profitability. Salesforce delivered adjusted EPS of $5.90, compared with consensus near $3.27. Adjusted EPS also rose from $2.91 a year earlier. Revenue reached about $11.3B, while the higher earnings figure gave investors a stronger result than the sales number alone would have delivered.
There is an important qualification. Reuters-linked coverage reported a $2.6B gain from strategic investments tied to Salesforce's Anthropic stake. That gain helped net income and EPS, so the result was not purely operational. Still, the combination of a large adjusted EPS beat, higher guidance, and a concrete AI product agreement explains why the market reacted so forcefully.
The reaction also exceeded the options market's setup. One pre-earnings measure priced an expected move of about 6.28%, below CRM's latest 10.34% extended-hours gain. Recent rating updates mostly reaffirmed existing views, which further supports earnings and AI news as the primary drivers rather than a fresh analyst upgrade.
Salesforce FY27 Guidance Puts AI Revenue in Focus
Salesforce raised fiscal 2027 revenue guidance to $46.1B to $46.4B. The range implies 11% to 12% year-over-year growth. Guidance carries more weight than a single quarterly EPS figure because it shows how management views demand across the rest of the fiscal year.
The AI story also gained a harder financial edge. Salesforce said annual recurring revenue from AI and data products is approaching $4B. Management tied the raised outlook to momentum in Agentforce, Data 360, and Slack. Those figures turn AI from a broad technology theme into a subscription and workflow expansion story.
The expanded Anthropic relationship adds another layer. The companies announced Claudeforce, a plug-in that combines Salesforce capabilities with Anthropic's Claude models. The arrangement gives enterprise customers a direct path to use AI agents inside existing workflows. If that integration drives more Agentforce and Data 360 subscriptions, the $4B ARR figure provides a base for further growth. The partnership itself, however, does not replace proof of recurring customer demand.
CRM Valuation and Salesforce's Enterprise Competitive Moat
Salesforce enters this reaction as a large, profitable software company rather than an early-stage AI venture. The stock data shows a market capitalization of $168.40B, EPS of $8.64, and a P/E ratio of 23.8. It also carries a 0.82% dividend yield. That valuation gives investors a useful starting point: CRM needs sustained earnings and revenue execution to justify a sharp repricing.
The business has a durable base. Salesforce sells subscription software across sales, service, marketing, commerce, analytics, integration, and collaboration. Recurring contracts create revenue visibility, while the broad product suite can increase the value of each enterprise relationship. The platform also benefits from a large installed base among sales and service organizations.
Competition remains serious. Microsoft, Oracle, HubSpot, Adobe, ServiceNow, and specialized SaaS vendors all compete for pieces of the customer workflow. Salesforce's breadth is its main defense, but enterprise buyers still demand proof that AI improves productivity and revenue. Agentforce must therefore expand the platform's economic value, not simply add another feature with an impressive label.
CRM's latest print remains below its 52-week high of $267.75 and above its 52-week low of $146.32. That range shows both room for recovery and the volatility investors have already experienced. A 10.34% jump changes the entry price quickly, even when the underlying business remains attractive.
The strongest bullish point is the alignment between earnings and outlook. Adjusted EPS beat consensus by a wide margin, FY27 revenue guidance moved to $46.1B to $46.4B, and AI and data ARR is nearing $4B. Together, those facts support a view that Salesforce is gaining traction in enterprise AI while protecting its core subscription engine.
The disciplined counterpoint is earnings quality. The $2.6B investment gain boosted the quarter, and that type of gain does not repeat like subscription revenue. Investors assessing CRM after the jump should place greater weight on the $46.1B to $46.4B revenue outlook and the near-$4B AI and data ARR figure than on the headline EPS alone.
Analyst sentiment provides support, but it is not the main catalyst. The latest consensus shows a Buy rating, with 72 buy ratings, 21 holds, 2 sells, and 2 strong buys. The consensus price target is $259.57, while the latest D.A. Davidson target listed at $200 sits below the extended-hours print. That spread argues for selectivity instead of treating every target as a promise.
Forward momentum depends on conversion. Salesforce has supplied higher revenue guidance, near-term AI ARR scale, and a named Anthropic integration. The investment case strengthens if those assets produce durable subscription growth and operating earnings. It weakens if AI demand remains mostly a narrative while investment gains carry the profit statement.
Salesforce, Inc. (CRM) is climbing because its fiscal Q2 report combined a major adjusted EPS beat with higher FY27 guidance and a more tangible AI partnership. The surge improves the growth narrative, but the $2.6B investment gain makes a clean reading of operating performance essential. The extended-hours move is powerful; regular-session price action will determine whether investors accept the new valuation.
CRM is up after Salesforce reported fiscal Q2 2027 results, raised full-year revenue guidance, and announced an expanded Anthropic partnership. The stock also benefited from a much larger-than-expected adjusted EPS beat.
+Should I buy CRM stock now?
The earnings and guidance update are bullish, but part of the EPS beat came from a $2.6 billion investment gain. Investors may want to focus on whether Salesforce can turn its near-$4 billion AI and data ARR into durable growth before buying aggressively.
+Did Salesforce beat earnings this quarter?
Yes. Salesforce reported adjusted EPS of $5.90 versus consensus near $3.27. Revenue was about $11.3 billion, and management also raised its full-year outlook.
+What does the Anthropic partnership mean for Salesforce investors?
The expanded Anthropic deal gives Salesforce a more concrete AI product story, especially around Agentforce and workflow automation. It supports the growth narrative, but investors still need proof that the partnership drives recurring customer demand and revenue.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on CRM?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.
